Ipsen Biopharmaceuticals, Inc

MA · United States · Reporting entity ID 100000000123

Total reported 2019–2025

$102.0M

#92 of 2,960 reporting companies — 0.1% of all reported industry payments

$20.0M in general payments across 82,935 records, plus $82.0M in research funding across 1,651 records.

How it breaks down

General payments $20,010,178

Research funding $82,031,733

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.